Jobs / United States / Sanofi US Services INC
Therapeutic Specialist Tzield, Kansas City, MO
Sanofi US Services INC · 🇺🇸 St. Louis, MO
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 47 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 29 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Sanofi US Services INC
The US Department of Labor certified 47 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 29 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Sanofi US Services INC →
About the role
Job Title: Therapeutic Specialist Tzield, Kansas City, MO Location: US Remote About the Job: Therapeutic Specialist, Tzield are part of the National Tzield Sales Team and play a pivotal role in bringing a paradigm-shifting Type 1 Diabetes product to market. Therapeutic Specialists leverage their deep sales experience and expertise to accelerate Tzield adoption across providers and accounts and collaborate closely with all respective cross-functional partners. This role will develop territory-specific sales strategies, educate endocrinology and primary care providers on both Tzield and screening, and build a robust Tzield customer base. We are an innovative global healthcare company with a focus on immunology that extends to innovation in diabetes and transplant medicine. Across different countries, our talented teams are determined to deliver a best-in-class customer experience using the best of digital, artificial intelligence and personal know-how. With a focus on immunology that extends to innovation in diabetes and transplant medicines, we pursue progress to make a real impact on millions of patients around the world. Join the team transforming care for people with immune challenges, rare diseases, cancers, and neurological conditions. In Specialty Care, you’ll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs. About Sanofi: We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve lives. Main Responsibilities • Brand Awareness & Intent to Treat with Endos • Build belief in Tzield mechanistic rationale and clinical narrative (e.g., MOA involving beta cell preservation, approved indication, efficacy / safety profile) • Develop in-depth knowledge and understanding of key accounts across territory, including barriers to Tzield use • Contribute to priority account strategy development lead by SAMs and own execution to engage endocrinology and primary care providers on Tzield use • For non-priority Endo in territories, own the development and execution of growth-oriented account & business plans (e.g., account mapping, influence mapping, etc.) • Identify account champions / KOLs, and engage them as necessary and appropriate to communicate with peers and patients about Tzield • Screening Awareness & Development of T1D Ecosystem • Build belief in T1D early detection and importance of screening for T1D in asymptomatic, undiagnosed, early detection population • Conduct strategic planning at territory level to understand and contribute to development of broader T1D ecosystem in order to prioritize time, engagement, and education strategy • Contribute to screening strategy development and own execution to engage PCP / Ped on early detection & screening • Collaborate with stakeholders to identify and educate on importance of urgent referrals for identified patients within narrow treatment window • Educate relevant stakeholders on at-risk populations, screening / monitoring best practices, and the value of early detection (e.g., DKA avoidance) Additional Responsibilities • Collaborate closely with cross-functional Sanofi teams to support customers • Attending local, regional, and national meetings as directed • Maintaining strict adherence to all legal, regulatory, ethical, administrative, and financial duties • Achieving and exceeding assigned monthly, quarterly, and annual sales quotas About You: Basic Qualifications • Bachelor´s degree. • 3+ years of pharmaceutical, bi